JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Sexually Transmitted Disease

Infected Individual
Obligatory

See:
Is there is a specific entry for the disease?

Must not donate

Discretionary

If fully treated, at least three months from completion of treatment, accept. Additionally, for gonorrhoea, evidence of a test of cure after treatment is required. This may be a verbal confirmation, provided by the donor.

See if Relevant

Tissues Safety Entry
Chlamydia
Genital Warts
Herpes - Genital
Syphilis

Sexual Partner
Obligatory

See:
Is there is a specific entry for the disease with which there has been contact?

Must not donate if:
a) Donor required treatment and it is less than three months since completing that treatment.

b) Donor did not require treatment and it is less than three months from the last sexual contact with the infected partner.

Discretionary

a) Donor did not require treatment and it is more than three months since the infected partner has completed treatment, accept.

b) Donor required treatment: if fully treated, and if it is at least three months from completion of treatment, accept. Additionally, for gonorrhoea, evidence of a test of cure after treatment is required. This may be a verbal confirmation, provided by the donor.

c) If the donor’s sexual partner has been diagnosed with chlamydia (except lymphogranuloma venereum, see (b) above), genital warts or genital herpes and the donor is asymptomatic and not undergoing treatment or investigation, accept.

See if Relevant

Tissues Safety Entry
Chlamydia
Genital Warts
Herpes - Genital
Syphilis

Additional Information

Guidelines (NICE, BASHH) recommend that current sexual partners of lymphogranuloma venereum (LGV) probable or confirmed individuals should receive testing and empiric treatment with a chlamydial regimen. They can be accepted 3 months after completion of treatment.

Reason for Change

Discretionary’ section for ‘sexual partner’ updated following FAIR III report. Clarification added regarding test of cure for gonorrhoea. ‘Additional Information’ section added.

Update Information

This entry was last updated in
TDSG-BM Edition 203, Release 52